Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

By Linderholm B.   Andersson J.   Lindh B.   Beckman L.   Erlanson M.   Edin K.   Tavelin B.   Grankvist K.   Henriksson R.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

c-erbB-2 Expression and Benefit From Adjuvant Chemotherapy and Radiotherapy of Breast Cancer

By Stal O.   Sullivan S.   Wingren S.   Skoog L.   Rutqvist L.E.   Carstensen J.M.   Nordenskjold B.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2185-2190

Elsevier

Access to resources Recommend Favorite

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients - effect of adjuvant chemotherapy

By Poikonen P.   Saarto T.   Elomaa I.   Joensuu H.   Blomqvist C.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Plasma c-erbB2 Concentrations in Relation to Chemotherapy in Breast Cancer Patients

By Revillion F.   Hebbar M.   Bonneterre J.   Peyrat J.P.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 231-234

Elsevier

Access to resources Recommend Favorite

Clinical Utility of Serial Serum c-erbB-2 Determinations in the Follow-up of Breast Cancer Patients

By Fehm T.   Gebauer G.   Jäger W.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 2, 2002-09 ,pp. : 97-106

Springer Publishing Company

Access to resources Recommend Favorite